An investigational antidote, andexanet alfa, was proven to reverse the anti-coagulation activity of apixaben. The US Food and Drug Administration gave the antidote "breakthrough therapy" status, according to MD Magazine.
↧
Channel:
Becker's Spine Review
X
Are you the publisher?
Claim or
contact us
about this channel.
X
0
Channel Details:
- Title: Becker's Spine Review
- Channel Number: 5415529
- Language: English
- Registered On: October 25, 2012, 11:53 am
- Number of Articles: 24331
- Latest Snapshot: March 11, 2025, 1:37 am
- RSS URL: http://beckersorthopedicandspine.com/home?format=feed&type=rss
- Publisher: https://www.beckersspine.com/
- Description: Beckers Orthopedic & Spine Review is a leading resource offering news and analysis on business...
- Catalog: //spine249.rssing.com/catalog.php?indx=5415529
© 2025 //www.rssing.com